Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $263,169 | 99 | 68.8% |
| Unspecified | $107,956 | 27 | 28.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,020 | 5 | 2.6% |
| Honoraria | $1,600 | 1 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Senseonics, Incorporated | $149,339 | 44 | $0 (2024) |
| Abbott Laboratories | $111,014 | 66 | $0 (2024) |
| Edwards Lifesciences Corporation | $49,400 | 6 | $0 (2019) |
| ShockWave Medical, Inc | $32,945 | 6 | $0 (2019) |
| ALCRESTA THERAPEUTICS, INC. | $19,233 | 6 | $0 (2021) |
| Broncus Medical | $19,015 | 3 | $0 (2021) |
| BioCardia, Inc. | $1,800 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33,554 | 14 | Abbott Laboratories ($24,616) |
| 2023 | $24,660 | 12 | Senseonics, Incorporated ($13,805) |
| 2022 | $21,630 | 14 | Abbott Laboratories ($11,610) |
| 2021 | $33,235 | 17 | Abbott Laboratories ($20,318) |
| 2020 | $34,184 | 20 | Abbott Laboratories ($16,824) |
| 2019 | $94,498 | 25 | Senseonics, Incorporated ($59,579) |
| 2018 | $84,057 | 18 | Senseonics, Incorporated ($38,817) |
| 2017 | $56,928 | 12 | Edwards Lifesciences Corporation ($39,800) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Senseonics, Incorporated | Eversense (Device) | Consulting Fee | Cash or cash equivalent | $2,007.50 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Consulting Fee | Cash or cash equivalent | $3,368.75 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Consulting Fee | Cash or cash equivalent | $2,062.50 | General |
| Category: Diabetes Care | ||||||
| 11/14/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Consulting Fee | Cash or cash equivalent | $2,612.50 | General |
| Category: Diabetes Care | ||||||
| 08/16/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Consulting Fee | Cash or cash equivalent | $2,268.75 | General |
| Category: Diabetes Care | ||||||
| 07/22/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Consulting Fee | Cash or cash equivalent | $893.75 | General |
| Category: Diabetes Care | ||||||
| 06/18/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Consulting Fee | Cash or cash equivalent | $3,422.50 | General |
| Category: Diabetes Care | ||||||
| 04/29/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Consulting Fee | Cash or cash equivalent | $1,703.75 | General |
| Category: Diabetes Care | ||||||
| 03/20/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Consulting Fee | Cash or cash equivalent | $1,880.00 | General |
| Category: Diabetes Care | ||||||
| 03/14/2024 | Senseonics, Incorporated | Eversense (Device) | Consulting Fee | Cash or cash equivalent | $660.00 | General |
| Category: Endocrinology | ||||||
| 02/16/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Consulting Fee | Cash or cash equivalent | $3,055.00 | General |
| Category: Diabetes Care | ||||||
| 01/25/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Consulting Fee | Cash or cash equivalent | $3,348.75 | General |
| Category: Diabetes Care | ||||||
| 01/25/2024 | Senseonics, Incorporated | Eversense (Device) | Consulting Fee | Cash or cash equivalent | $3,135.00 | General |
| Category: Endocrinology | ||||||
| 01/25/2024 | Senseonics, Incorporated | Eversense (Device) | Consulting Fee | Cash or cash equivalent | $3,135.00 | General |
| Category: Endocrinology | ||||||
| 12/19/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Consulting Fee | Cash or cash equivalent | $2,056.25 | General |
| Category: Diabetes Care | ||||||
| 12/18/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Consulting Fee | Cash or cash equivalent | $1,938.75 | General |
| Category: Diabetes Care | ||||||
| 10/26/2023 | Senseonics, Incorporated | Eversense (Device) | Consulting Fee | Cash or cash equivalent | $3,685.00 | General |
| Category: Endocrinology | ||||||
| 10/18/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Consulting Fee | Cash or cash equivalent | $1,233.75 | General |
| Category: Diabetes Care | ||||||
| 10/03/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Consulting Fee | Cash or cash equivalent | $1,057.50 | General |
| Category: Diabetes Care | ||||||
| 08/03/2023 | Senseonics, Incorporated | Eversense (Device) | Consulting Fee | Cash or cash equivalent | $2,035.00 | General |
| Category: Endocrinology | ||||||
| 05/12/2023 | Senseonics, Incorporated | Eversense (Device) | Consulting Fee | Cash or cash equivalent | $3,135.00 | General |
| Category: Endocrinology | ||||||
| 04/28/2023 | Senseonics, Incorporated | Eversense (Device) | Consulting Fee | Cash or cash equivalent | $1,705.00 | General |
| Category: Endocrinology | ||||||
| 04/14/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Consulting Fee | Cash or cash equivalent | $1,773.75 | General |
| Category: Diabetes Care | ||||||
| 03/17/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Consulting Fee | Cash or cash equivalent | $1,988.75 | General |
| Category: Diabetes Care | ||||||
| 02/16/2023 | Senseonics, Incorporated | Eversense (Device) | Consulting Fee | Cash or cash equivalent | $3,245.00 | General |
| Category: Endocrinology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PRECISION Study (Eversense CGM Supplemetary Clinical Study) | Senseonics, Incorporated | $38,817 | 9 |
| PROMISE (A Prospective, Multicenter Evaluation of Accuracy and Safety of an Implantable Continuous Glucose Sensor Lasting up to 180 Days) | Senseonics, Incorporated | $34,439 | 5 |
| PROMISE and PAS (Medical Affairs Support) | Senseonics, Incorporated | $31,400 | 11 |
| Performance Evaluation of Continuous Glucose Monitoring System | Abbott Laboratories | $3,300 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 474 | 710 | $271,167 | $72,441 |
| 2022 | 6 | 304 | 407 | $180,323 | $47,383 |
| 2021 | 7 | 554 | 961 | $208,438 | $82,900 |
| 2020 | 7 | 259 | 351 | $171,316 | $45,381 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 189 | 371 | $135,415 | $39,135 | 28.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 114 | 116 | $43,848 | $11,796 | 26.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 77 | 79 | $55,616 | $11,296 | 20.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 94 | 144 | $36,288 | $10,215 | 28.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 117 | 118 | $79,910 | $20,527 | 25.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 78 | 162 | $51,834 | $14,659 | 28.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 40 | 40 | $14,342 | $3,815 | 26.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 38 | 56 | $12,257 | $3,556 | 29.0% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $12,080 | $2,905 | 24.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 11 | 11 | $9,900 | $1,921 | 19.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 141 | 352 | $70,400 | $29,396 | 41.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 138 | 151 | $67,048 | $24,748 | 36.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 113 | 288 | $40,896 | $17,079 | 41.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 115 | 123 | $17,466 | $7,189 | 41.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 15 | 15 | $6,810 | $2,124 | 31.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 18 | 18 | $3,690 | $1,547 | 41.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 14 | 14 | $2,128 | $816.62 | 38.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 132 | 134 | $93,666 | $23,924 | 25.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 58 | 142 | $51,120 | $14,025 | 27.4% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 14 | 14 | $7,602 | $2,361 | 31.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 17 | 17 | $6,324 | $1,669 | 26.4% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2020 | 11 | 11 | $4,279 | $1,315 | 30.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 19 | $4,769 | $1,130 | 23.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 14 | 14 | $3,556 | $957.21 | 26.9% |
About Dr. Grace Carlson, MD
Dr. Grace Carlson, MD is a Internal Medicine healthcare provider based in Berkeley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1558514109.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Grace Carlson, MD has received a total of $382,745 in payments from pharmaceutical and medical device companies, with $33,554 received in 2024. These payments were reported across 132 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($263,169).
As a Medicare-enrolled provider, Carlson has provided services to 1,591 Medicare beneficiaries, totaling 2,429 services with total Medicare billing of $248,105. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Berkeley, CA
- Active Since 10/28/2008
- Last Updated 11/09/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1558514109
Products in Payments
- Eversense (Device) $149,339
- FreeStyle Libre (Device) $48,755
- FREESTYLE LIBRE (Device) $43,086
- Vascular Lithotripsy (Device) $19,445
- RELIZORB (Device) $19,233
- FreeStyle Libre Pro (Device) $13,800
- VASCULAR LITHOTRIPSY (Device) $13,500
- FREESTYLE LIBRE 2 (Device) $3,995
- Circulatory Support (Device) $1,378
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Berkeley
Dr. David Rempel, Md, MD
Internal Medicine — Payments: $828,552
Oleg Krijanovski, Md, Phd, MD, PHD
Internal Medicine — Payments: $271,706
Dr. Laura Wilson, M.d, M.D
Internal Medicine — Payments: $35,060
Dr. Denise Davis, M.d, M.D
Internal Medicine — Payments: $12,000
Harneet Chopra, Md, MD
Internal Medicine — Payments: $8,736
Dr. Xin Yang, Mb Bchir, MB BCHIR
Internal Medicine — Payments: $7,281